The World’s Largest Commercial Collection of Well-Characterized Patient Derived Xenograft Models
2500+ models represent over 30 cancer types to test novel therapeutic uses for existing molecules
A large collection enables population studies to stratify patients into responders, partial and non-responders, and to look for molecular signatures of response
HuPrime® Solid Tumor PDX
HuKemia® Blood Cancer PDX
Our ALL and AML Models are Unique in the Commercial World
Presenting stable disease transferable through passages, providing the only models that truly represent the human condition and that can be used to test the efficacy of novel agents against drug resistance. Why not add your project to the ever increasing 110 client blood cancer studies we’ve already completed?
All CrownBio models are well-characterized and all genomic, genetic, pathology, and response annotations are accessed via HuBase™, our online searchable PDX database, and OncoExpress™, our powerful new search engine.